Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.000
+0.160 (4.17%)
At close: Jan 22, 2026, 4:00 PM EST
4.080
+0.080 (2.00%)
After-hours: Jan 22, 2026, 6:46 PM EST
Organogenesis Holdings Revenue
Organogenesis Holdings had revenue of $150.86M in the quarter ending September 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to $465.22M, up 2.24% year-over-year. In the year 2024, Organogenesis Holdings had annual revenue of $482.04M with 11.29% growth.
Revenue (ttm)
$465.22M
Revenue Growth
+2.24%
P/S Ratio
1.05
Revenue / Employee
$535,349
Employees
869
Market Cap
509.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.04M | 48.90M | 11.29% |
| Dec 31, 2023 | 433.14M | -17.75M | -3.94% |
| Dec 31, 2022 | 450.89M | -16.47M | -3.52% |
| Dec 31, 2021 | 467.36M | 129.06M | 38.15% |
| Dec 31, 2020 | 338.30M | 77.32M | 29.63% |
| Dec 31, 2019 | 260.98M | 67.53M | 34.91% |
| Dec 31, 2018 | 193.45M | -5.06M | -2.55% |
| Dec 31, 2017 | 198.51M | 59.78M | 43.09% |
| Dec 31, 2016 | 138.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 788.90M |
| Esperion Therapeutics | 303.80M |
| Evolus | 285.82M |
| Akebia Therapeutics | 225.07M |
| Canopy Growth | 200.02M |
| Kamada | 174.79M |
| SIGA Technologies | 172.25M |
| Lifecore Biomedical | 128.87M |
ORGO News
- 4 weeks ago - Organogenesis Announces Initiation of Biologics License Application for ReNu® - GlobeNewsWire
- 5 weeks ago - Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - GlobeNewsWire
- 6 weeks ago - Organogenesis: High-Tech Skin Substitute Company On Sale - Seeking Alpha
- 2 months ago - Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance - GlobeNewsWire
- 2 months ago - Organogenesis Applauds CMS's Significant Step In Payment Reform - GlobeNewsWire
- 2 months ago - Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO - Business Wire